UTERINE NEOPLASMS
Clinical trials for UTERINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UTERINE NEOPLASMS trials appear
Sign up with your email to follow new studies for UTERINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug duo targets Hard-to-Treat cancers in major trial
Disease control OngoingThis study is testing whether the drugs tucatinib and trastuzumab can help control advanced solid tumors that have specific changes in a protein called HER2. It is for adults with cancers like lung, cervical, or uterine cancer that have spread or cannot be removed by surgery, and…
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC